Results 31 to 40 of about 8,626 (206)

The Prevalence and Incidence of Clinical and Asymptomatic Lyme Borreliosis in a Population at Risk [PDF]

open access: yes, 1991
^A past history of clinical Lyme borreliosis and the 6-month incidence of clinical and asymptomatic Lyme borreliosis was studied prospectively in a high-risk population. In the spring, blood samples were drawn from 950 Swiss orienteers, who also answered
Van Der Linden, Sjef M.   +11 more
core   +1 more source

Uveitis and Lyme borreliosis. [PDF]

open access: yesBritish Journal of Ophthalmology, 1993
In a retrospective study 56 consecutive patients with uveitis of unknown origin and 56 consecutive patients suffering from uveitis of established aetiology were investigated. The purpose of this study was to determine the frequency of positive serological tests for Lyme borreliosis among patients with uveitis and to relate laboratory data to clinical ...
Breeveld, J.   +4 more
openaire   +2 more sources

Gender disparity between cutaneous and non-cutaneous manifestations of Lyme borreliosis.

open access: yesPLoS ONE, 2013
Cutaneous manifestations of Lyme borreliosis in Europe include erythema migrans (EM) and acrodermatitis chronica atrophicans (ACA); the most common non-cutaneous manifestations are Lyme neuroborreliosis (LNB) and Lyme arthritis. The purpose of this study
Franc Strle   +13 more
doaj   +1 more source

Lyme disease. Pediatric Aspects (II Part)

open access: yesZdorovʹe Rebenka, 2014
Up to 25 % of all patients with Lyme borreliosis — children aged 5–9 years. In children also have three clinical and pathogenetic stages of Lyme disease.
V.V. Mavrutenkov
doaj   +1 more source

Lower Frequency of Multiple Erythema Migrans Skin Lesions in Lyme Reinfections, Europe

open access: yesEmerging Infectious Diseases
The erythema migrans (EM) skin lesion is the most common clinical manifestation of Lyme borreliosis. Information about EM in Lyme borreliosis reinfection is limited.
Franc Strle   +8 more
doaj   +1 more source

Studying the Circulation of Etiological Agent of Lyme Borreliosis in Stavropol Region

open access: yesПроблемы особо опасных инфекций, 2008
Using polymerase chain reaction with reverse transcription (RT-PCR) rRNA tick-borne borreliosis (Lyme borreliosis) etiological agent was detected in suspensions of ticks Ixodes ricinus. Infection rate was 7.1 %.
T. N. Orlova   +5 more
doaj   +1 more source

A Fatal Case of Late Stage Lyme Borreliosis and Substance Abuse

open access: yesJournal of Affective Disorders Reports, 2023
A recent study demonstrated a 1,100% (12-fold) increase in substance abuse after acquiring Lyme borreliosis. Lyme borreliosis and substance abuse have never been adequately studied and deserves greater attention.
RC Bransfield, ME Embers, AJ Dwork
doaj   +1 more source

Lyme Borreliosis During Pregnancy

open access: yes, 2012
One of the authors (AL) presented a poster on 34 pregnancies of maternal Lyme borreliosis (Lb) in 1995. It was striking that untreated Lb associated with higher probability of adverse outcome but the number of patients were small and the statistical ...
András Lakos, Norbert Solymosi
core   +1 more source

The HUMTICK study: protocol for a prospective cohort study on post-treatment Lyme disease syndrome and the disease and cost burden of Lyme borreliosis in Belgium

open access: yesArchives of Public Health, 2017
Background In Belgium, different routine surveillance systems are in place to follow-up Lyme borreliosis trends. However, accurate data on the disease and monetary burden for the different clinical manifestations are lacking.
Laurence Geebelen   +8 more
doaj   +1 more source

The Performance of Nine Commercial Serological Screening Assays for the Diagnosis of Lyme Borreliosis: a Multicenter Modified Two-Gate Design Study

open access: yesMicrobiology Spectrum, 2022
In this retrospective study, the performance of nine serological screening assays for Lyme borreliosis (LB) diagnostics was evaluated using a study population of LB cases and controls.
B. J. A. Hoeve-Bakker   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy